CN
China Suppliers > cqkl > Details for Cilostazol
| 111Category: | Pharmaceuticals and Biochemicals/Cardiovascular agents |
|
|
| CAS NO: | 73963-72-1 | ||
| EC NO: | |||
| Molecular Formula: | C20H27N5O2 | ||
| Molecular Weight: | 369.4607 | ||
| Specification: | USP33 JP16 | ||
| InChI: | InChI=1/C20H27N5O2/c26-20-12-9-15-14-17(10-11-18(15)21-20)27-13-5-4-8-19-22-23-24-25(19)16-6-2-1-3-7-16/h10-11,14,16H,1-9,12-13H2,(H,21,26) | ||
| Packing: | 25KGS/DRUM | ||
| Product description: GMP USA DMF 22463 JDMF 224mf10046 JP16 USP33 Antithrombotic;Phosphodiesterase Inhibitor Platelet aggregation Inhibitor Treatment for intermittent claudication. |
|||
| Uses: | Treatment for intermittent claudication | ||
| Synonyms: | 6-[4-(1-cyclohexyl-1h-tetrazol-5-yl)butoxy]-3,4-dihydro-2(1h)-quinolinone;6-[4-(1-cyclohexyl-5-tetrazolyl)butoxy]-1,2,3,4-tetrahydro-2-oxoquinolinone;Cilostazole;6-[4-(1-cyclohexyl-1H-tetrazol-5-yl)butoxy]-3,4-dihydroquinolin-2(1H)-one; | ||
| Molecular Structure: |
 |
||
Search Product